News
 

Indicators of early-life cognitive enrichment (ELCE) have been associated with slower cognitive decline and decreased dementia in late life.

This recent retrospective cohort study included the review of medical records of patients with isolated or recurrent transient global amnesia (TGA) who presented at the Mayo Clinic in Rochester, Minnesota, between August 1, 1992 and February 28, 2018. A total of 1491 cases were examined and 1044 met the diagnostic inclusion criteria for TGA, while...

To determine whether escitalopram (ESC) treatment would decrease CSF beta 42 amyloid levels compared to placebo (Aβ42), a study has recently been conducted (Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults. A controlled clinical trial. Yvette I. Sheline, B. Joy Snider, Joanne C. Beer, Darsol Seok, Anne M....

The variability of postural changes in systolic blood pressure is associated with an increased risk of dementia according to a new study.

Periodontal disease is associated with later development of mild cognitive impairment (MCI) or dementia, especially in those with severe gum inflammation and edentulism (tooth loss), new research suggests (published online July 29 in Neurology)

Atherosclerosis of the internal carotid artery (ICA) is an important cause of ischemic stroke. Artery-to-artery embolism is the major stroke mechanism in patients with atherosclerotic carotid disease. This study published in BMC Neurology (20, Article number: 288 (2020) hypothesized that the atherosclerotic ICA geometry and plaque location would be...

Many emergency physicians use an intravenous fluid bolus as part of a 'cocktail' of therapies

Infection increases mortality risk among patients with dementia, new research suggests.

To determine whether a history of cerebrovascular disease (CVD) increases risk of severe coronavirus disease 2019 (COVID-19) a retrospective multicenter study has been conducted from COVID-19 registries of three hospitals in Saxony, Germany.

Australian researchers have made a breakthrough in Alzheimer's research, demonstrating what they describe as the first gene therapy-based approach to treating advanced forms of the disease.